Eupraxia is a clinical-stage biotechnology company focused on developing locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. Diffusphere™, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing and novel drugs. The technology is designed to support an extended duration of effect and delivery of drugs in a hyper-localized fashion, targeting only the tissues that physicians want to treat. We believe the potential for fewer adverse events may be achieved through the precision targeting and the stable and flat delivery of the active ingredient when using the Diffusphere™ technology, versus the peaks and troughs seen with more traditional drug delivery methods. The precision of Eupraxia's Diffusphere™ technology platform has the potential to augment and transform existing FDA-approved drugs to improve their safety, tolerability, efficacy and duration of effect. The potential uses in therapeutic areas may go beyond pain and inflammatory gastrointestinal disease, where Eupraxia currently is developing advanced treatments, also to be applicable in oncology, infectious disease and other critical disease areas. EP-104GI is administered as an injection into the esophageal wall, providing local delivery of drug. In addition, Eupraxia is developing a pipeline of later and earlier-stage long-acting formulations. Potential pipeline indications include candidates for GI diseases, inflammatory diseases and oncology, each designed to improve on the activity and tolerability of currently approved drugs. For further details about Eupraxia, please visit the Company's website at:



Eupraxia Pharmaceuticals is seeking a dynamic Director of Intellectual Property with extensive experience within the biotech/pharma space. This position will be responsible for managing intellectual property matters critical to the Company’s success, counselling senior Company business leaders, developing and implementing patent portfolio strategies, coordinating outside IP counsel, gathering IP competitive intelligence, and coordinating IP due diligence in support of business transactions. The successful candidate will have significant depth of experience in diverse aspects of patent law practice, high technical competency in the life sciences, and will be adept at serving as a trusted business advisor Candidates must be able to work in person from either our Seattle or Vancouver office a minimum of two days per week Own the Company’s global patent strategy across all product candidates and platform technologies, aligning filing decisions with commercial and regulatory exclusivity objectives. Direct outside counsel in drafting, filing and prosecuting — worldwide applications (provisional, PCT, national phase), and manage the patent lifecycle, including continuations, divisionals, patent term adjustment/extension, and Orange Book (or equivalent) listing decisions. Maintain the IP asset register and portfolio maps by molecule, indication, formulation, method of use, and manufacturing process, mapped against expected commercial life.



Freedom-to-operate and competitive intelligence Perform initial exploratory freedom-to-operate analyses for Eupraxia’s development programs and to support potential licensing transactions As required on a case-by-case basis, coordinate with external counsel formal freedom-to-operate analyses for Eupraxia’s programs or for licensing transactions Monitor the competitor and third-party patent landscape and developing IP law, and brief R&D; and executive leadership on developments affecting program risk or chance. Support Business Development and Finance in performing due diligence for potential financing, licensing, collaboration, and sponsored research agreements Support Legal, Business Development and External Counsel during negotiation of IP terms for licensing, collaboration, sponsored research, material transfer, CDA/NDA, and manufacturing/supply agreements, Partner with regulatory affairs and external counsel on the interplay between patent strategy and regulatory exclusivities (NCE/data, orphan drug, patent term extension) across FDA, Health Canada, and EMA, and partner with investor relations on IP-related disclosure. Trade secrets, enforcement, and risk management Assess and manage inventorship, ownership, and freedom-to-operate risk arising from collaborations, academic license-ins, and contract research/manufacturing relationships. Support the Executive Team and external counsel in coordinating opposition, re-examination, IPR, and litigation strategy Maintain the trademark portfolio for corporate and product brands. Own the IP budget and manage a network of outside patent firms across key jurisdictions for cost-effective, high-quality execution. Report portfolio status, key risks, and strategic recommendations to the executive team on a reg

📌 Director of Medical Policy (Canada)
🏢 Eupraxia Pharmaceuticals
📍 Canada